Human Genome Sciences Moving Higer, Up 4% (HGSI)

by Roger Nachman, Benzinga Staff Writer

November 15, 2010 10:42 AM | 13 seconds read | Make a Comment

Human Genome Sciences

HGSI

is moving higher today, up more than 4%, as investors await a key U.S. regulatory panel meeting for its lupus drug, Benlysta. At last check, shares of HGSI were up 89 cents to $24.49.

Market News and Data brought to you by Benzinga APIs

Posted In: Movers Biotechnology Health Care

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Human Genome Sciences Moving Higer, Up 4% (HGSI)